Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

pemetrexed

  • You have access
    Phase II trial of Pemetrexed Continuation – Maintenance after Carboplatin-based Induction in Untreated Non-squamous Non-small Cell Lung Cancer
    SEIGO MINAMI, TAKASHI KIJIMA, KIYOSHI KOMUTA, TORU KUMAGAI, FUMIO IMAMURA, SOICHIRO YOKOTA, YOSHIKO TAKEUCHI, TAKESHI NAKATANI, ISAO TACHIBANA and ICHIRO KAWASE
    Anticancer Research December 2013, 33 (12) 5535-5542;
  • You have access
    Pemetrexed and Cisplatin for Advanced Non-squamous Non-small Cell Lung Cancer in Japanese Patients: Phase II Study
    YUKO KAWANO, FUMIYOSHI OHYANAGI, NORIKO YANAGITANI, KEITA KUDO, ATSUSHI HORIIKE, AZUSA TANIMOTO, HIRONARI NISHIZAWA, ATSUO ICHIKAWA, TOSHIO SAKATANI, KATSUMI NAKATOMI, SACHIKO HAGIWARA, HIRONORI NINOMIYA, NORIKO MOTOI, YUICHI ISHIKAWA, TAKESHI HORAI and MAKOTO NISHIO
    Anticancer Research August 2013, 33 (8) 3327-3333;
  • You have access
    Sequential Treatment of Advanced-stage Lung Adenocarcinoma Harboring Wild-type EGFR Gene: Second-line Pemetrexed Followed by Third-line Erlotinib versus the Reverse Sequence
    ONDREJ FIALA, MILOS PESEK, JINDRICH FINEK, LUCIE BENESOVA, ZBYNEK BORTLICEK and MAREK MINARIK
    Anticancer Research August 2013, 33 (8) 3397-3402;
  • You have access
    Changes in Thymidine Phosphorylase Gene Expression Related to Treatment of Rectal Cancer
    KRISTOFFER DERWINGER, ELINOR BEXE LINDSKOG, ERIK PALMQVIST and YVONNE WETTERGREN
    Anticancer Research June 2013, 33 (6) 2447-2451;
  • You have access
    Long-term Follow-up after Preoperative Chemotherapy Using Pemetrexed (Alimta) in Rectal Cancer
    TORBJÖRN SWARTLING, KARL KODEDA, BENGT GUSTAVSSON and KRISTOFFER DERWINGER
    Anticancer Research January 2013, 33 (1) 325-327;
  • You have access
    Pemetrexed plus Carboplatin or Cisplatin as Neoadjuvant Treatment of Operable Malignant Pleural Mesothelioma (MPM)
    GIULIA PASELLO, GIUSEPPE MARULLI, VALENTINA POLO, CRISTIANO BREDA, LAURA BONANNO, LUCIO LOREGGIAN, FEDERICO REA and ADOLFO FAVARETTO
    Anticancer Research December 2012, 32 (12) 5393-5399;
  • You have access
    Association between Expression of Thymidylate Synthase, Dihydrofolate Reductase, and Glycinamide Ribonucleotide Formyltransferase and Efficacy of Pemetrexed in Advanced Non-small Cell Lung Cancer
    TETSUO SHIMIZU, YOKO NAKANISHI, YOSHIKO NAKAGAWA, ICHIRO TSUJINO, NORIAKI TAKAHASHI, NORIMICHI NEMOTO and SHU HASHIMOTO
    Anticancer Research October 2012, 32 (10) 4589-4596;

Pages

  • Previous
  • 1
  • 2
  • 3
Anticancer Research

© 2023 Anticancer Research

Powered by HighWire